Advertisement

Topics

Artizan Bio gets $12mm in Series A funding

15:40 EDT 13 Jun 2019 | Elsevier Business Intelligence

Gastrointestinal disease-focused Artizan Biosciences Inc. raised $12mm in its Series A financing to Hatteras Venture Partners...

Original Article: Artizan Bio gets $12mm in Series A funding

NEXT ARTICLE

More From BioPortfolio on "Artizan Bio gets $12mm in Series A funding"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...